Reinforced Poly(Propylene Carbonate) Composite with Enhanced and Tunable Characteristics, an Alternative for Poly(lactic Acid)

• Published in: ACS applied materials & interfaces Vol. 7; no. 40; pp. 22421 - 22430
• Main Authors: Manavitehrani, Iman, Fathi, Ali, Wang, Yiwei, Maitz, Peter K, Dehghani, Fariba
• Format: Journal Article
• Language: English
• Published: United States American Chemical Society 14.10.2015
• Subjects: Animals; Biocompatible Materials - chemistry; Biocompatible Materials - pharmacology; Calorimetry, Differential Scanning; Cell Adhesion - drug effects; Cell Line; Cell Proliferation - drug effects; Elastic Modulus; Humans; Lactic Acid - chemistry; Male; Mice; Mice, Inbred BALB C; Polyesters; Polymers - chemistry; Polypropylenes - chemistry; Prostheses and Implants; Spectroscopy, Fourier Transform Infrared; Starch - chemistry; Thermogravimetry; biodegradable; starch; poly(propylene carbonate); poly(lactic acid); composite
• ISSN: 1944-8244; 1944-8252
• DOI: 10.1021/acsami.5b06407

The acidic nature of the degradation products of polyesters often leads to unpredictable clinical complications, such as necrosis of host tissues and massive immune cell invasions. In this study, poly­(propylene carbonate) (PPC) and starch composite is introduced with superior characteristics as an alternative to polyester-based polymers. The degradation products of PPC–starch composites are mainly carbon dioxide and water; hence, the associated risks to the acidic degradation of polyesters are minimized. Moreover, the compression strength of PPC-starch composites can be tuned over the range of 0.2 ± 0.03 MPa to 33.9 ± 1.51 MPa by changing the starch contents of composites to address different clinical needs. More importantly, the addition of 50 wt % starch enhances the thermal processing capacity of the composites by elevating their decomposition temperature from 245 to 276 °C. Therefore, thermal processing methods, such as extrusion and hot melt compression methods can be used to generate different shapes and structures from PPC–starch composites. We also demonstrated the cytocompatibility and biocompatibility of these composites by conducting in vitro and in vivo tests. For instance, the numbers of osteoblast cells were increased 2.5 fold after 7 days post culture. In addition, PPC composites in subcutaneous mice model resulted in mild inflammatory responses (e.g., the formation of fibrotic tissue) that were diminished from two to 4 weeks postimplantation. The long-term in vivo biodegradation of PPC composites are compared with poly­(lactic acid) (PLA). The histochemical analysis revealed that after 8 weeks, the biodegradation of PLA leads to massive immune cell infusion and inflammation at the site, whereas the PPC composites are well-tolerated in vivo. All these results underline the favorable properties of PPC–starch composites as a benign biodegradable biomaterial for fabrication of biomedical implants.